drugset / Trial / NCT01704794

Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract)

NCT01704794

Phase 1/2 Unknown 96 enrolled Lagos State University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the antioxidant effect of prolonged use of sorghum bicolor (jobelyn) to increase the level of plasma superoxide dismutase and glutathione reductase in patients with sickle cell disease and to determine if there is any improvement in the quality of life of the patients.

Timeline

Start
2013-04
Primary completion
2014-04
Completion
2014-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Jobelyn Traditional medicine (herbal / TCM) 250 mg
Comparator Proguanil Small molecule 20 mg
Comparator Proguanil Small molecule 40 mg
Comparator folic acid Other / unclassified 5 mg

Indications